{
  "id": "autologous-cell-therapy-market-forecast-to-reach-44-55b-by-2033",
  "title": "Autologous cell therapy market forecast to reach $44.55b by 2033",
  "summary": "The global autologous cell therapy market—therapies derived from a patient’s own cells to treat disease—is projected to grow significantly, reaching approximately USD 44.55 billion by 2033, according to a new market research report. This expansion, led by firms such as BrainStorm Cell Therapeutics, reflects rising demand for personalised cell‑based treatments that minimise immune rejection and improve therapeutic […] The post Autologous cell therapy market forecast to reach $44.55b by 2033 appeared first on Longevity.Technology.",
  "url": "https://longevity.technology/news/autologous-cell-therapy-market-forecast-to-reach-44-55-b-by-2033/",
  "source": "Longevity.Technology",
  "author": "LT Staff",
  "category": "news",
  "publishedAt": "2026-01-30T11:46:08.000Z",
  "fetchedAt": "2026-02-04T10:49:05.818Z",
  "relevanceScore": 0.2,
  "matchedKeywords": [
    "longevity"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:49:05.890Z"
}